Long‐term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
Why the study?
Does the presence of NAFLD predict long-term clinical outcomes in patients undergoing coronary angiogram?
Population
612 consecutive patients requiring coronary angiogram
Comparison
Presence of nonalcoholic fatty liver disease… vs Absence of NAFLD
Design
Cohort
Follow-up
3,679 patient-years
Authors
Discussion
Loading...
Member takes
Implication
NAFLD screening before angiography does not add prognostic value in CAD; leaves open utility in other high-risk groups.
Structured PICO
Does the presence of NAFLD predict long-term clinical outcomes in patients undergoing coronary angiogram?
P
Population
612 consecutive patients requiring coronary angiogram
I
Intervention
Presence of nonalcoholic fatty liver disease (NAFLD) diagnosed by abdominal ultrasonography screening
C
Comparator
Absence of NAFLD
O
Outcome
Mortality and composite cardiovascular outcomes (cardiovascular deaths, nonfatal myocardial infarction, heart failure, or secondary interventions)composite
In patients undergoing coronary angiography, the presence of NAFLD is associated with more severe coronary stenosis but does not predict increased long-term cardiovascular complications or mortality, suggesting routine screening may not be clinically useful for risk stratification in this population.
Limitations
- studies with a longer duration of follow-up are needed
Cite This Study
Wong et al. (2015) studied this question.